CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients

Oral Oncology

Volumn 45, Issue 9, 2009, Pages

  Olivieri, Eloisa Helena Ribeiro ^a,b   da Silva, Sabrina Daniela ^b   Mendonça, Fernando Fernandes ^a   Urata, Yuri Nagamine ^a   Vidal, Daniel Onofre ^a   Faria, Marcilia de Araujo Medrado ^c   Nishimoto, Inês Nobuko ^b   Rainho, Claudia Aparecida ^a   Kowalski, Luiz Paulo ^b   Rogatto, Silvia Regina ^a,b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Clinical outcome; Cytochrome P450; Genetic polymorphisms; Glutathione S transferases; Head and neck squamous cell carcinoma

Indexed keywords

CYTOCHROME P450 1A; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE M1; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE T1;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; FEMALE; GENETIC POLYMORPHISM; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TOBACCO; TUMOR GROWTH; BRAZIL; CASE CONTROL STUDY; COPY NUMBER VARIATION; DRINKING BEHAVIOR; GENETICS; HEAD AND NECK TUMOR; METHODOLOGY; MIDDLE AGED; PROGNOSIS; RISK FACTOR; SMOKING;

ALCOHOL DRINKING; BRAZIL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2E1; DNA COPY NUMBER VARIATIONS; FEMALE; GLUTATHIONE TRANSFERASE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SMOKING;

EID: 68949198135     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.03.004     Document Type: Article

References (61)

1. Penel N., Amela E.Y., Mallet Y., Lefebvre D., Clisant S., Kara A., et al. A simple predictive model for postoperative mortality after head and neck cancer surgery with opening of mucosa. Oral Oncol 43 2 (2007) 174-180
2. Gallegos-Hernández J.F. Head and neck cancer. Risk factors and prevention. Cir Cir 74 4 (2006) 287-293
3. Frank S.A. Genetic variation in cancer predisposition: mutational decay of a robust genetic control network. Proc Natl Acad Sci USA 101 21 (2004) 8061-8065
4. Vineis P., Alavanja M., Buffler P., Fontham E., Franceschi S., Gao Y.T., et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 96 2 (2004) 99-106
5. Franco E.L., Kowalski L.P., Oliveira B.V., Curado M.P., Pereira R.N., Silva M.E., et al. Risk factors for oral cancer in Brazil: a case-control study. Int J Cancer 43 6 (1989) 992-1000
6. Goldenberg D., Lee J., Koch W.M., Kim M.M., Trink B., Sidransky D., et al. Habitual risk factors for head and neck cancer. Otolaryngol Head Neck Surg 131 6 (2004) 986-993
7. Viswanathan H., and Wilson J.A. Alcohol - the neglected risk factor in head and neck cancer. Clin Otolaryngol Allied Sci 29 4 (2004) 295-300
8. Negri E., Boffetta P., Berthiller J., Castellsague X., Curado M.P., Dal Maso L., et al. Family history of cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Int J Cancer 124 2 (2009) 394-401
9. Garavello W., Foschi R., Talamini R., La Vecchia C., Rossi M., Dal Maso L., et al. Family history and the risk of oral and pharyngeal cancer. Int J Cancer 122 8 (2008) 1827-1831
10. Ingelman-Sundberg M. Genetic variability in susceptibility and response to toxicants. Toxicol Lett 120 1-3 (2001) 259-268
11. Báez A. Genetic and environmental factors in head and neck cancer genesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 26 2 (2008) 174-200
12. Li W.H., Gu Z., Wang H., and Nekrutenko A. Evolutionary analyses of the human genome. Nature 409 (2001) 847-849
13. Shastry B.S. SNP alleles in human disease and evolution. J Hum Genet 47 (2002) 561-566
14. Olshan A.F., Weissler M.C., Watson M.A., and Bell D.A. GSTM1, GSTT1, GSTP1, CYP1A1 and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 9 (2000) 185-191
15. Cho E.Y., Yun C.H., Chae H.Z., Chae H.J., and Ahn T. Lysophosphatidylserine-induced functional switch of human cytochrome P4501A2 and 2E1 from monooxygenase to phospholipase D. Biochem Biophys Res Commun 376 3 (2008) 584-589
16. Coon M.J. Cytochrome P450: nature's most versatile biological catalyst. Annu Rev Pharmacol Toxicol 45 (2005) 1-25
17. Guengerich F.P. Cytochrome P450: what have we learned and what are the future issues?. Drug Metab Rev 36 2 (2004) 159-197
18. Conney A.H. Induction of drug-metabolizing enzymes: a path to the discovery of multiple cytochromes P450. Annu Rev Pharmacol Toxicol 43 (2003) 1-30
19. Lu A.Y. Drug-metabolism research challenges in the new millennium: individual variability in drug therapy and drug safety. Drug Metab Dispos 26 12 (1998) 1217-1222
20. Hayes J.D., Flanagan J.U., and Jowsey I.R. Glutathione transferases. Annu Rev Pharmacol Toxicol 45 (2005) 51-88
21. Soya S.S., Vinod T., Reddy K.S., Gopalakrishnan S., and Adithan C. Genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population. Eur J Cancer 43 18 (2007) 2698-2706
22. Reszka E., Czekaj P., Adamska J., and Wasowicz W. Relevance of glutathione S-transferase M1 and cytochrome P4501A1 genetic polymorphisms to the development of head and neck cancers. Clin Chem Lab Med 46 8 (2008) 1090-1096
23. Bethke L., Webb E., Sellick G., Rudd M., Penegar S., Withey L., et al. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. BMC Cancer 7 (2007) 123
24. Bolufer P., Barragan E., Collado M., Cervera J., López J.A., and Sanz M.A. Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 30 12 (2006) 1471-1491
25. Kiyohara C. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer. J Epidemiol 10 5 (2000) 349-360
26. Kihara M., Kihara M., and Noda K. Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 16 10 (1995) 2331-2336
27. Telles E.E. Racial ambiguity among the Brazilian population. Ethn Racial Stud 25 (2002) 415-441
28. Sobin L.H., and Wittelind C.H. International union against cancer: TNM classification of malignant tumours. 6th ed. (2002), Wiley, New York
29. Wahi P.N., Cohen B., Luthra U.K., and Torloni H. Histological typing of oral and oropharyngeal tumours (1971), World Health Organization, Geneva p. 28
30. Wong N.A., Rae F., Simpson K.J., Murray G.D., and Harrison D.J. Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis. Mol Pathol 53 2 (2000) 88-93
31. Chida M., Yokoi T., Fukui T., Kinoshita M., Yokota J., and Kamataki T. Detection of three genetic polymorphisms in the 5′-flanking region and intron 1 of human CYP1A2 in the Japanese population. Jpn J Cancer Res 90 9 (1999) 899-902
32. Nakajima M., Yokoi T., Mizutani M., Kinoshita M., Funayama M., and Kamataki T. Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem (Tokyo) 125 4 (1999) 803-808
33. Hayashi S., Watanabe J., Nakachi K., and Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem 110 (1991) 407-411
34. Rossini A., Rapozo D.C., Amorim L.M., Macedo J.M., Medina R., Neto J.F., et al. Frequencies of GSTM1, GSTT1, and GSTP1 polymorphisms in a Brazilian population. Genet Mol Res 1 3 (2002) 233-240
35. Boccia S., Cadoni G., Sayed-Tabatabaei F.A., Volante M., Arzani D., De Lauretis A., et al. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol 134 1 (2008) 93-100
36. Nebert D.W., Dalton T.P., Okey A.B., and Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279 23 (2004) 23847-23850
37. Moyer A.M., Salavaggione O.E., Hebbring S.J., Moon I., Hildebrandt M.A., Eckloff B.W., et al. Glutathione S-transferase T1 and M1: gene sequence variation and functional genomics. Clin Cancer Res 13 23 (2007) 7207-7216
38. Argiris A., Karamouzis M.V., Raben D., and Ferris R.L. Head and neck cancer. Lancet 371 9625 (2008) 1695-1709
39. Sturgis E.M., Wei Q., and Spitz M.R. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol 31 6 (2004) 726-733
40. Scully C., Field J.K., and Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma: 2. Chromosomal aberrations. Oral Oncol 36 (2000) 311-327
41. Gattás G.J., de Carvalho M.B., Siraque M.S., Curioni O.A., Kohler P., Eluf-Neto J., et al. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck 28 9 (2006) 819-826
42. Hashibe M., Brennan P., Strange R.C., Bhisey R., Cascorbi I., Lazarus P., et al. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 12 12 (2003) 1509-1517
43. Varela-Lema L., Taioli E., Ruano-Ravina A., Barros-Dios J.M., Anantharaman D., Benhamou S., et al. Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genet Med 10 6 (2008) 369-384
44. Ghotbi R., Christensen M., Roh H.K., Ingelman-Sundberg M., Aklillu E., and Bertilsson L. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans. Eur J Clin Pharmacol 63 6 (2007) 537-546
45. Rossini A., Lima S.S., Rapozo D.C., Faria M., Albano R.M., and Pinto L.F. CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro. Braz J Med Biol Res 39 2 (2006) 195-201
46. Pimenta J.R., Zuccherato L.W., Debes A.A., Maselli L., Soares R.P., Moura-Neto R.S., et al. Color and genomic ancestry in Brazilians: a study with forensic microsatellites. Hum Hered 2 (2006) 190-195
47. Parra F.C., Amado R.C., Lambertucci J.R., Rocha J., Antunes C.M., and Pena S.D. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 100 (2003) 177-182
48. Butura A., Nilsson K., Morgan K., Morgan T.R., French S.W., Johansson I., et al. The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. J Hepatol (2008) 25 [Epub ahead of print]
49. Lu Y., and Cederbaum A.I. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 44 5 (2008) 723-738
50. dos Reis P.P., Poli-Frederico R.C., dos Santos R.M., Nishimoto I.N., Kowalski L.P., and Rogatto S.R. Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas. Med Sci Monit 8 3 (2002) BR89-BR94
51. Matthias C., Jahnke V., Jones P.W., Hoban P.R., Alldersea J.E., Worrall S.F., et al. Cyclin D1, glutathione S-transferase, and cytochrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: assessment of the importance of individual genes using multivariate analysis. Cancer Epidemiol Biomarkers Prev 8 9 (1999) 815-823
52. Hung H.C., Chuang J., Chien Y.C., Chern H.D., Chiang C.P., Kuo Y.S., et al. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 6 11 (1997) 901-905
53. Marques C.F., Koifman S., Koifman R.J., Boffetta P., Brennan P., and Hatagima A. Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro. Oral Oncol 42 6 (2006) 632-637
54. Singh M.N., Stringfellow H.F., Walsh M.J., Ashton K.M., Paraskevaidis E., Abdo K.R., et al. Quantifiable mRNA transcripts for tamoxifen-metabolising enzymes in human endometrium. Toxicology 249 1 (2008) 85-90
55. Tiwari A.K., Deshpande S.N., Rao A.R., Bhatia T., Mukit S.R., Shriharsh V., et al. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism. Pharmacogenomics J 5 1 (2005) 60-69
56. Chong S.A., Tan E.C., Tan C.H., and Mythily S. Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene. J Psychiatry Neurosci 28 3 (2003) 185-189
57. Oyama T., Sugio K., Uramoto H., Kawamoto T., Kagawa N., Nadaf S., et al. Cytochrome P450 expression (CYP) in non-small cell lung cancer. Front Biosci 12 (2007) 2299-2308
58. Bolt H.M., Roos P.H., and Thier R. The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int Arch Occup Environ Health 76 3 (2003) 174-185
59. Kowalski L.P., Bagietto R., Lara J.R., Santos R.L., Silva Jr. J.F., and Magrin J. Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck 22 3 (2000) 207-214
60. Pimenta Amaral T.M., Da Silva Freire A.R., Carvalho A.L., Pinto C.A., and Kowalski L.P. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol 40 8 (2004) 780-786
61. Fletcher A.M., Heaford A.C., and Trask D.K. Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205. Transl Oncol 1 4 (2008) 202-208